AN2 THERAPEUTICS INC (ANTX) Stock Analyst Ratings
NASDAQ:ANTX - Nasdaq - US0373261058 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 50% to ANTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.72. This target is 140.71% above the current price.
ANTX was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about ANTX.
In the last month the buy percentage fell by 26 points. So the trust of analysts is decreasing.
ANTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-18 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-08-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-03 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-05-16 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-04-02 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2024-04-01 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-13 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-02-12 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-02-12 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-02-12 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-01-04 | JMP Securities | Initiate | Market Outperform |
| 2023-03-30 | Oppenheimer | Maintains | Outperform |
| 2022-11-14 | SVB Leerink | Maintains | Outperform |
| 2022-04-19 | Oppenheimer | Initiate | Outperform |
| 2022-04-19 | Cowen & Co. | Initiate | Outperform |
| 2022-04-19 | Evercore ISI Group | Initiate | Outperform |